Search Results - Andrew M. Rogers

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    Videolaryngoscopy versus direct laryngoscopy for adults undergoing tracheal intubation

    Videolaryngoscopy versus direct laryngoscopy for adults undergoing tracheal intubation by Jan Hansel, Andrew M. Rogers, Sharon R Lewis, Tim Cook, Andrew F Smith

    Published 2022
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Videolaryngoscopy versus direct laryngoscopy for adults undergoing tracheal intubation: a Cochrane systematic review and meta-analysis update

    Videolaryngoscopy versus direct laryngoscopy for adults undergoing tracheal intubation: a Cochrane systematic review and meta-analysis update by Jan Hansel, Andrew M. Rogers, Sharon R Lewis, Tim Cook, Andrew F Smith

    Published 2022
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Multiple Mutations and Bypass Mechanisms Can Contribute to Development of Acquired Resistance to MET Inhibitors

    Multiple Mutations and Bypass Mechanisms Can Contribute to Development of Acquired Resistance to MET Inhibitors by Jie Qi, Michele McTigue, Andrew M. Rogers, Eugene Lifshits, James G. Christensen, Pasi A. Jänne, Jeffrey A. Engelman

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Noninvasive Detection of <i>EGFR</i> T790M in Gefitinib or Erlotinib Resistant Non–Small Cell Lung Cancer

    Noninvasive Detection of <i>EGFR</i> T790M in Gefitinib or Erlotinib Resistant Non–Small Cell Lung Cancer by Yanan Kuang, Andrew M. Rogers, Beow Y. Yeap, Xin Lin, Mike Makrigiorgos, Kristi Vetrand, Sara Thiede, R Distel, Pasi A. Jänne

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Autocrine Production of Amphiregulin Predicts Sensitivity to Both Gefitinib and Cetuximab in <i>EGFR</i> Wild-type Cancers

    Autocrine Production of Amphiregulin Predicts Sensitivity to Both Gefitinib and Cetuximab in <i>EGFR</i> Wild-type Cancers by Kimio Yonesaka, Kreshnik Zejnullahu, Neal I. Lindeman, Alison J. Homes, David M. Jackman, Feng Zhao, Andrew M. Rogers, Bruce E. Johnson, Pasi A. Jänne

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Calcineurin Orchestrates Lateral Transfer of <i>Aspergillus fumigatus</i> during Macrophage Cell Death

    Calcineurin Orchestrates Lateral Transfer of <i>Aspergillus fumigatus</i> during Macrophage Cell Death by Anand Shah, Shichina Kannambath, Susanne Herbst, Andrew M. Rogers, Simona Soresi, M. Carby, Anna Reed, Serge Mostowy, Matthew C. Fisher, Sunil Shaunak, Darius Armstrong‐James

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor

    Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor by Dalia Ercan, Kreshnik Zejnullahu, Kimio Yonesaka, Yun Xiao, Marzia Capelletti, Andrew M. Rogers, Eugene Lifshits, Alyssa Brown, Charles Lee, James G. Christensen, David J. Kwiatkowski, Jeffrey A. Engelman, Pasi A. Jänne

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    The COVID-19 pandemic is intricately linked to biodiversity loss and ecosystem health

    The COVID-19 pandemic is intricately linked to biodiversity loss and ecosystem health by Odette K Lawler, Hannah Allan, P. W. J. Baxter, Romi Castagnino, Marina Corella Tor, Leah E Dann, Joshua Hungerford, Dibesh Karmacharya, Thomas J. Lloyd, María José López, Gloeta N. Massie, Junior Novera, Andrew M. Rogers, Salit Kark

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients

    Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients by Jussi Koivunen, J. Kim, J. Lee, Andrew M. Rogers, J O Park, Xiao‐Jun Zhao, Katsuhiko Naoki, Isamu Okamoto, Kazuhiko Nakagawa, B.Y. Yeap, Matthew Meyerson, Kwok‐Kin Wong, William G. Richards, David J. Sugarbaker, Bruce E. Johnson, Pasi A. Jänne

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    <i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

    <i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling by Jeffrey A. Engelman, Kreshnik Zejnullahu, Tetsuya Mitsudomi, Youngchul Song, Courtney Hyland, Joon Oh Park, Neal I. Lindeman, Christopher-Michael Gale, Xiao‐Jun Zhao, James G. Christensen, Takayuki Kosaka, Alison J. Holmes, Andrew M. Rogers, Federico Cappuzzo, Tony Mok, Charles Lee, Bruce E. Johnson, Lewis C. Cantley, Pasi A. Jänne

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC

    Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC by Alexa B. Turke, Kreshnik Zejnullahu, Yi‐Long Wu, Youngchul Song, Dora Dias‐Santagata, Eugene Lifshits, Luca Toschi, Andrew M. Rogers, Tony Mok, Lecia V. Sequist, Neal I. Lindeman, Carly Murphy, Sara Akhavanfard, Beow Y. Yeap, Yun Xiao, Marzia Capelletti, A. John Iafrate, Charles Lee, James G. Christensen, Jeffrey A. Engelman, Pasi A. Jänne

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Reactivation of ERK Signaling Causes Resistance to EGFR Kinase Inhibitors

    Reactivation of ERK Signaling Causes Resistance to EGFR Kinase Inhibitors by Dalia Ercan, Chunxiao Xu, Masahiko Yanagita, Calixte S. Monast, Christine A. Pratilas, Joan Montero, Mohit Butaney, Takeshi Shimamura, Lynette M. Sholl, Elena Ivanova, Madhavi Tadi, Andrew M. Rogers, Claire E. Repellin, Marzia Capelletti, Ophélia Maertens, Eva M. Goetz, Anthony Letai, Levi A. Garraway, Matthew J. Lazzara, Neal Rosen, Nathanael S. Gray, Kwok‐Kin Wong, Pasi A. Jänne

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab

    Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab by Kimio Yonesaka, Kreshnik Zejnullahu, Isamu Okamoto, Taroh Satoh, Federico Cappuzzo, John Souglakos, Dalia Ercan, Andrew M. Rogers, Massimo Roncalli, Masayuki Takeda, Yasuhito Fujisaka, Juliet Philips, Toshio Shimizu, Osamu Maenishi, Yong Gon Cho, Jason Sun, Annarita Destro, Koichi Taira, Koji Takeda, Takafumi Okabe, Jeffrey Swanson, Ito H, Minoru Takada, Eugene Lifshits, Kiyotaka Okuno, Jeffrey A. Engelman, Ramesh A. Shivdasani, Kazuto Nishio, Masahiro Fukuoka, Marileila Varella‐Garcia, Kazuhiko Nakagawa, Pasi A. Jänne

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: